Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis

  • End date
    May 15, 2021
  • participants needed
  • sponsor
Updated on 11 November 2020
Pfizer CT.gov Call Center
Primary Contact
Department of Rheumatology, Northern Jiangsu People's Hospital (2.0 mi away) Contact
+43 other location
rheumatic diseases
plaque psoriasis


This is a 6 month study investigating the effectiveness and safety of tofacitinib in treating signs and symptoms and improving physical function in Chinese patients with active psoriatic arthritis and had inadequate response to a conventional synthetic disease modifying anti-rheumatic drug. This is a China alone study.

Treatment Placebo, tofacitinib
Clinical Study IdentifierNCT03486457
Last Modified on11 November 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.


Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 18 yrs?
Gender: Male or Female
Do you have any of these conditions: Arthritis and Arthritic Pain or Arthritis or Psoriasis and Psoriatic Disorders or Psoriasis or PSORIATIC ARTHRITIS or Arthritis and Arthritic Pain (Pe...?
Do you have any of these conditions: Arthritis or Arthritis and Arthritic Pain (Pediatric) or PSORIATIC ARTHRITIS or Psoriasis and Psoriatic Disorders or Arthritis and Arthritic Pain or P...?
Chinese patients
Active arthritis at screening/baseline as indicated by >/= 3 tender/painful and 3 swollen joints
Active plaque psoriasis at screening
Inadequate response to at least one conventional synthetic DMARD

Exclusion Criteria

Non-plaque forms of psoriasis (with exception of nail psoriasis)
History of autoimmune rheumatic disease other than PsA; also prior history of or current, rheumatic inflammatory disease other than PsA
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer


user name

Annotated by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No made yet